View ValuationASP Isotopes 将来の成長Future 基準チェック /26ASP Isotopesは、36.2%と47.1%でそれぞれ年率36.2%で利益と収益が成長すると予測される一方、EPSはgrowで47.2%年率。主要情報36.2%収益成長率47.16%EPS成長率Chemicals 収益成長18.2%収益成長率47.1%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日13 Apr 2026今後の成長に関する最新情報Price target increased by 41% to US$12.00 Feb 14Forecast to breakeven in 2028 Feb 14Consensus revenue estimates fall by 32% Sep 18Price target increased by 29% to US$11.00 Aug 15Price target increased by 18% to US$6.50 Feb 14Forecast to breakeven in 2026 Feb 14すべての更新を表示Recent updatesASP Isotopes Inc. announced delayed annual 10-K filingApr 01Asp Isotopes Inc Completes Well Drilling Required for Phase 1 of Renergen Helium ProjectMar 23ASP Isotopes: Needs More Proof Mar 10New minor risk - Profitability Mar 09Executive Chairman & CEO notifies of intention to sell stock Mar 05Price target increased by 41% to US$12.00 Feb 14Forecast to breakeven in 2028 Feb 14ASP Isotopes Inc. Provides Production Update on the Renergen Helium ProjectJan 29ASP Isotopes Inc. Announces Executive AppointmentsJan 13ASP Isotopes Inc. (NasdaqCM:ASPI) completed the acquisition of Renergen Limited (JSE:REN) from Mazi Asset Management (Pty) Ltd, Matc Investments Pty Ltd, CRT investments Pty. Ltd., Anchor Capital (Pty) Ltd., Ivy Asset Management LLC, Ye Jia and others.Jan 07Asp Isotopes Inc. Announces That Paul Mann to Return from Temporary Leave of Absence as Executive ChairmanDec 03Asp Isotopes Inc. Announces Paul Mann to Return from Temporary Leave of Absence as Chief Executive Officer, Effective January 19, 2026Dec 02ASP Isotopes Inc., Annual General Meeting, Dec 18, 2025Nov 26ASP Isotopes Inc. announced delayed 10-Q filingNov 15COO & Interim CEO notifies of intention to sell stock Oct 18ASP Isotopes Inc. has completed a Follow-on Equity Offering in the amount of $210.3 million.Oct 15+ 1 more updateIndependent Director notifies of intention to sell stock Oct 02ASP Isotopes Inc. Announces Paul Mann Becomes Executive Chairman, Effective October 1, 2025Sep 30Consensus revenue estimates fall by 32% Sep 18President notifies of intention to sell stock Sep 11Asp Isotopes Inc. Appoints Ralph Hunter to Board of Directors, Effective as of September 8, 2025Sep 08Independent Director notifies of intention to sell stock Aug 31Price target increased by 29% to US$11.00 Aug 15ASP Isotopes Inc. has filed a Follow-on Equity Offering in the amount of $60 million.Jul 24ASP Isotopes Inc. Announces Updates on the Progress of Commercial Production At Its Three Enrichment Facilities in South AfricaJul 17ASP Isotopes Inc. has filed a Follow-on Equity Offering in the amount of $50 million.Jun 03ASP Isotopes Inc. (NasdaqCM:ASPI) entered into agreement to acquire Renergen Limited (JSE:REN) from Mazi Asset Management (Pty) Ltd, Matc Investments Pty Ltd, CRT investments Pty. Ltd., Anchor Capital (Pty) Ltd., Ivy Asset Management LLC, Ye Jia and others.May 21ASP Isotopes Inc. announced delayed 10-Q filingMay 16ASP Isotopes Inc. has filed a Follow-on Equity Offering in the amount of $25 million.May 01President notifies of intention to sell stock Apr 17ASP Isotopes Inc. Announces Board ChangesApr 16Asp Isotopes Inc. Completes Commissioning of First Quantum Enrichment Laser System and Starts Production of Commercial Samples of Ytterbium-176Apr 01ASP Isotopes Inc. to Report Q4, 2024 Results on Mar 31, 2025Mar 31Asp Isotopes Inc. Commences Commercial Production of Enriched Silicon-28 At Its Second Aerodynamic Separation Process (Asp) Enrichment FacilityMar 27Asp Isotopes Inc. Commences Commercial Production of Enriched Carbon-14 At Its First Aerodynamic Separation Process (Asp) Enrichment FacilityFeb 26Price target increased by 18% to US$6.50 Feb 14Forecast to breakeven in 2026 Feb 14ASP Isotopes: Too Hot To Handle Jan 25Asp Isotopes Inc Announces Filing of Class Action LawsuitDec 05ASP Isotopes Inc. announced delayed 10-Q filingNov 15Forecast to breakeven in 2026 Nov 14ASP Isotopes Inc. has completed a Follow-on Equity Offering in the amount of $16.16625 million.Nov 02ASP Isotopes Inc. has filed a Follow-on Equity Offering.Nov 01ASP Isotopes Inc., Annual General Meeting, Nov 20, 2024Oct 22ASP Isotopes Inc. Enriches Ytterbium-176 During Commissioning Phase of First Quantum Enrichment FacilityOct 17ASP Isotopes Inc. announced delayed 10-Q filingAug 15New major risk - Shareholder dilution Jul 14ASP Isotopes Inc. has filed a Follow-on Equity Offering.Jul 13+ 1 more updateHigh number of new and inexperienced directors Jun 29ASP Isotopes Inc. Appoints Heather Kiessling as Its Chief Financial Officer, Effective as of July 1, 2024Jun 16ASP Isotopes Inc. announced delayed annual 10-K filingMar 30ASP Isotopes Inc. announced that it expects to receive $20 million in fundingFeb 19ASP Isotopes Inc. Announces Board ChangesJan 19High number of new and inexperienced directors Dec 31ASP Isotopes Inc. Announces Executive ChangesOct 20ASP Isotopes Inc. announced that it expects to receive $8.1945 million in funding from Tees River Critical Resources Fund LimitedOct 11Forecast to breakeven in 2024 Aug 15ASP Isotopes Inc. announced delayed 10-Q filingMay 16ASP Isotopes Receives Non-Compliance Notice From NasdaqMay 11ASP Isotopes Inc. has completed an IPO in the amount of $5 million.Nov 11業績と収益の成長予測NasdaqCM:ASPI - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2028257-90N/AN/A212/31/202783-105515312/31/202631-106-13-3312/31/202524-175-47-38N/A9/30/20258-106-34-24N/A6/30/20255-100-31-20N/A3/31/20254-37-29-17N/A12/31/20244-35-28-17N/A9/30/20243-30-24-15N/A6/30/20242-27-16-11N/A3/31/20241-20-10-7N/A12/31/20230-16-8-5N/A9/30/2023N/A-13-6-4N/A6/30/2023N/A-11-8-4N/A3/31/2023N/A-8-8-4N/A12/31/2022N/A-5-7-3N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: ASPI今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: ASPI今後 3 年間、利益が出ない状態が続くと予測されています。高成長収益: ASPI今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: ASPIの収益 ( 47.1% ) US市場 ( 11.1% ) よりも速いペースで成長すると予測されています。高い収益成長: ASPIの収益 ( 47.1% ) 20%よりも速いペースで成長すると予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: ASPIの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/03 22:15終値2026/05/01 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋ASP Isotopes Inc. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関George GianarikasCanaccord Genuitynull nullCantor Fitzgerald & Co.Derek SoderbergCantor Fitzgerald & Co.1 その他のアナリストを表示
ASP Isotopes Inc. (NasdaqCM:ASPI) completed the acquisition of Renergen Limited (JSE:REN) from Mazi Asset Management (Pty) Ltd, Matc Investments Pty Ltd, CRT investments Pty. Ltd., Anchor Capital (Pty) Ltd., Ivy Asset Management LLC, Ye Jia and others.Jan 07
Asp Isotopes Inc. Announces That Paul Mann to Return from Temporary Leave of Absence as Executive ChairmanDec 03
Asp Isotopes Inc. Announces Paul Mann to Return from Temporary Leave of Absence as Chief Executive Officer, Effective January 19, 2026Dec 02
ASP Isotopes Inc. has completed a Follow-on Equity Offering in the amount of $210.3 million.Oct 15+ 1 more update
Asp Isotopes Inc. Appoints Ralph Hunter to Board of Directors, Effective as of September 8, 2025Sep 08
ASP Isotopes Inc. Announces Updates on the Progress of Commercial Production At Its Three Enrichment Facilities in South AfricaJul 17
ASP Isotopes Inc. (NasdaqCM:ASPI) entered into agreement to acquire Renergen Limited (JSE:REN) from Mazi Asset Management (Pty) Ltd, Matc Investments Pty Ltd, CRT investments Pty. Ltd., Anchor Capital (Pty) Ltd., Ivy Asset Management LLC, Ye Jia and others.May 21
Asp Isotopes Inc. Completes Commissioning of First Quantum Enrichment Laser System and Starts Production of Commercial Samples of Ytterbium-176Apr 01
Asp Isotopes Inc. Commences Commercial Production of Enriched Silicon-28 At Its Second Aerodynamic Separation Process (Asp) Enrichment FacilityMar 27
Asp Isotopes Inc. Commences Commercial Production of Enriched Carbon-14 At Its First Aerodynamic Separation Process (Asp) Enrichment FacilityFeb 26
ASP Isotopes Inc. has completed a Follow-on Equity Offering in the amount of $16.16625 million.Nov 02
ASP Isotopes Inc. Enriches Ytterbium-176 During Commissioning Phase of First Quantum Enrichment FacilityOct 17
ASP Isotopes Inc. Appoints Heather Kiessling as Its Chief Financial Officer, Effective as of July 1, 2024Jun 16
ASP Isotopes Inc. announced that it expects to receive $8.1945 million in funding from Tees River Critical Resources Fund LimitedOct 11